Sam Eiber

Stock Analyst at BTIG

(0.31)

# 4,200

Out of 4,944 analysts

5

Total ratings

33.33%

Success rate

-18.65%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Sam Eiber

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	EOLS Evolus	Maintains: Buy	$21 → $18	$6.40	+181.25%	2	Aug 6, 2025
	INMD InMode	Downgrades: Neutral	n/a	$14.22	-	2	Apr 29, 2025
	APYX Apyx Medical	Initiates: Neutral	n/a	$2.27	-	1	Oct 17, 2024

Evolus

Aug 6, 2025

Maintains: Buy

Price Target: $21 → $18

Current: $6.40

Upside: +181.25%

InMode

Apr 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $14.22

Upside: -

Apyx Medical

Oct 17, 2024

Initiates: Neutral

Price Target: n/a

Current: $2.27

Upside: -